PARP enzyme
Showing 1 - 25 of 2,322
Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)
Recruiting
- Neuroendocrine Tumors
- Peptide Receptor Radionuclide Therapy
-
Rotterdam, South Holland, NetherlandsErasmus MC
May 19, 2023
Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))
Not yet recruiting
- Pheochromocytoma
- Paraganglioma
- [18F]FluorThanatrace ([18F]FTT)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Dec 1, 2022
Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)
Active, not recruiting
- Advanced Breast Cancer
- +2 more
- Talazoparib Tosylate
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Nov 16, 2022
Pancreatic Cancer Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))
Recruiting
- Pancreatic Cancer
- [18F]FluorThanatrace ([18F]FTT)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 18, 2021
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Pittsburgh (ZEN003694, Talazoparib)
Recruiting
- Ovarian Cancer
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Apr 27, 2022
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma Trial in United States
Recruiting
- Pancreatic Acinar Cell Carcinoma
- +6 more
- Biospecimen Collection
- +4 more
-
Anchorage, Alaska
- +357 more
Jan 28, 2023
Metastatic Breast Cancer Trial in Herlev, Vejle (PARP inhibitor 2X-121)
Active, not recruiting
- Metastatic Breast Cancer
- PARP inhibitor 2X-121
-
Herlev, Denmark
- +1 more
Feb 1, 2023
Atopic Dermatitis Trial in Adelaide (RBN-3143)
Recruiting
- Atopic Dermatitis
-
Adelaide, AustraliaCMAX Clinical Research Pty Ltd
Mar 10, 2022
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Retroperitoneal Sarcoma AJCC v8 Trial in Columbus
Not yet recruiting
- Locally Advanced Leiomyosarcoma
- +6 more
- Niraparib Tosylate Monohydrate
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 25, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +3 more
- Alpelisib
- +7 more
- (no location specified)
Jul 28, 2023
Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer
Recruiting
- Adrenal Gland Pheochromocytoma
- +3 more
- Computed Tomography
- +2 more
-
Bethesda, Maryland
- +1 more
Jan 3, 2023
Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)
Not yet recruiting
- Ovarian Cancer
- Olaparib tablet
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Nov 1, 2023
Breast Inflammatory Carcinoma Trial in Canada, Puerto Rico, United States (Olaparib, Radiation Therapy)
Recruiting
- Breast Inflammatory Carcinoma
- Olaparib
- Radiation Therapy
-
Anchorage, Alaska
- +183 more
Aug 20, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +5 more
- (no location specified)
Apr 8, 2023
Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)
Active, not recruiting
- Breast Cancer
- +3 more
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
Oral Cancer Trial in Varanasi (Aspirin 150 mg, Standard of care)
Recruiting
- Oral Cancer
- Aspirin 150 mg
- Standard of care
-
Varanasi, UP, IndiaBanaras Hindu University
May 23, 2023
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and
Not yet recruiting
- Recurrent Endometrial Carcinoma
- Recurrent Ovarian Carcinoma
- Biopsy
- +5 more
- (no location specified)
Sep 29, 2022
Breast Cancer Trial in Boston, Cambridge (Sapacitabine, Olaparib)
Active, not recruiting
- Breast Cancer
-
Boston, Massachusetts
- +1 more
May 2, 2022
Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8
Recruiting
- Locally Advanced Pancreatic Carcinoma
- +3 more
- Biopsy
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center EDDOP
Nov 30, 2022
Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in United States
Suspended
- Recurrent Ovarian High Grade Serous Adenocarcinoma
- Recurrent Platinum-Resistant Ovarian Carcinoma
-
Phoenix, Arizona
- +8 more
Jul 26, 2022
Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma Trial in
Recruiting
- Fallopian Tube Mucinous Adenocarcinoma
- +49 more
- Cediranib Maleate
- +5 more
-
Anchorage, Alaska
- +373 more
Aug 17, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Carboplatin
- +2 more
-
New Brunswick, New Jersey
- +2 more
Jun 28, 2022
Locally Advanced Unresectable Breast Carcinoma, Metastatic Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in United
Suspended
- Locally Advanced Unresectable Breast Carcinoma
- +3 more
- Atezolizumab
- +2 more
-
Phoenix, Arizona
- +57 more
Jul 27, 2022